Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
66
MDT Quote, Financials, Valuation and Earnings
Last price:
$100.89
Seasonality move
:
0.71%
Day range:
$100.56 - $102.05
52-week range:
$79.55 - $106.33
Dividend yield:
2.8%
P/E ratio:
27.31x
P/S ratio:
3.74x
P/B ratio:
2.66x
Volume:
10.4M
Avg. volume:
8.1M
1-year change:
10.83%
Market cap:
$129.6B
Revenue:
$33.5B
EPS (TTM):
$3.70
Analysts' Opinion
-
Consensus RatingMedtronic Plc has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 13 Buy ratings, 13 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $111.83, Medtronic Plc has an estimated upside of 10.64% from its current price of $101.08.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $100.00 representing 1.07% downside risk from its current price of $101.08.
Fair Value
-
According to the consensus of 26 analysts, Medtronic Plc has 10.64% upside to fair value with a price target of $111.83 per share.
MDT vs. S&P 500
-
Over the past 5 trading days, Medtronic Plc has underperformed the S&P 500 by -0.88% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medtronic Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medtronic Plc has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Medtronic Plc reported revenues of $9B.
Earnings Growth
-
Medtronic Plc has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Medtronic Plc reported earnings per share of $1.07.
Enterprise value:
150.6B
EV / Invested capital:
--
Price / LTM sales:
3.74x
EV / EBIT:
23.27x
EV / Revenue:
4.33x
PEG ratio (5yr expected):
2.11x
EV / Free cash flow:
28.92x
Price / Operating cash flow:
24.99x
Enterprise value / EBITDA:
15.87x
Gross Profit (TTM):
$20.8B
Return On Assets:
5.28%
Net Income Margin (TTM):
13.79%
Return On Equity:
9.84%
Return On Invested Capital:
6.21%
Operating Margin:
19.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | $32B | $33B | $34.8B | $8.4B | $9B | |
| Gross Profit | $19.2B | $19.8B | $20.8B | $5B | $5.4B | |
| Operating Income | $5.8B | $5.9B | $6.5B | $1.6B | $1.7B | |
| EBITDA | $8.5B | $8.6B | $9.5B | $2.3B | $2.5B | |
| Diluted EPS | $3.08 | $3.28 | $3.70 | $0.99 | $1.07 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $22.7B | $25.4B | $22.1B | $22.4B | $24B | |
| Total Assets | $91.8B | $93.2B | $90.1B | $90B | $91.3B | |
| Current Liabilities | $7.8B | $14.5B | $9.7B | $12.2B | $9.9B | |
| Total Liabilities | $39.6B | $41.2B | $38.4B | $41.3B | $42.5B | |
| Total Equity | $52.2B | $52.1B | $51.6B | $48.7B | $48.9B | |
| Total Debt | $25.6B | $26.6B | $25.1B | $28.3B | $29.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.6B | $7.2B | $7.1B | $958M | $925M | |
| Cash From Investing | -$1.7B | -$2B | -$2.5B | -$345M | -$482M | |
| Cash From Financing | -$7.6B | -$5.1B | -$4.9B | -$534M | -$395M | |
| Free Cash Flow | $4B | $5.5B | $5.2B | $554M | $457M | |
MDT
Sector
Market Cap
$129.6B
$23.4M
Price % of 52-Week High
95.06%
48.88%
Dividend Yield
2.8%
0%
Shareholder Yield
3.26%
-1.64%
1-Year Price Total Return
10.83%
-21.81%
Beta (5-Year)
0.709
0.504
Dividend yield:
2.8%
Annualized payout:
$2.80
Payout ratio:
66.55%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$102.22
200-day SMA
Buy
Level
$93.24
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$100.97
Relative Strength Index (RSI14)
Buy
Level
51.13
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-64.2442
50-day SMA
Buy
Level
$99.68
MACD (12, 26)
Buy
Level
0.87
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
--
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7138)
Buy
CA Score
(Annual)
Level (0.174)
Buy
Beneish M-Score
(Annual)
Level (-2.5748)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.0583)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stock Forecast FAQ
In the current month, MDT has received 13 Buy ratings 13 Hold ratings, and 0 Sell ratings. The MDT average analyst price target in the past 3 months is $111.83.
-
Where Will Medtronic Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medtronic Plc share price will rise to $111.83 per share over the next 12 months.
-
What Do Analysts Say About Medtronic Plc?
Analysts are divided on their view about Medtronic Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medtronic Plc is a Sell and believe this share price will drop from its current level to $100.00.
-
What Is Medtronic Plc's Price Target?
The price target for Medtronic Plc over the next 1-year time period is forecast to be $111.83 according to 26 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 13 analysts rate the stock a Hold.
-
Is MDT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medtronic Plc is a Leans Bullish. 13 of 26 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of MDT?
You can purchase shares of Medtronic Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medtronic Plc shares.
-
What Is The Medtronic Plc Share Price Today?
Medtronic Plc was last trading at $100.89 per share. This represents the most recent stock quote for Medtronic Plc. Yesterday, Medtronic Plc closed at $101.08 per share.
-
How To Buy Medtronic Plc Stock Online?
In order to purchase Medtronic Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MDT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MDT
Sector
P/E ratio
27.31x
23.34x
PEG ratio
2.11x
-0.01x
P/B ratio
2.66x
1.72x
Price / LTM sales
3.74x
1.51x
Growth Metrics
MDT
Sector
Revenue growth
6.64%
3.21%
Earnings growth
8.1%
10.12%
Revenue (5-year growth)
3.01%
6.27%
Earnings forecast
$1.34
-$0.19
Profitability
MDT
Sector
Profitability FY 2025
$20.1B
$2.7M
Return on invested capital
6.21%
-33.62%
Return on assets
5.28%
-29.68%
Return on equity
9.84%
-38.89%
Earnings Date
Last Earnings Date
Nov
18
Next Earnings Date
Feb
17
Estimated Next Earnings Date
Feb
17
Balance Sheet
MDT
Sector
Total cash
$8.3B
$25M
Short term investments
$6.7B
$23.9M
Total assets
$91.7B
$72.8M
Long term debt
$29.1B
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
66
DIOD alert for Feb 13
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
